Yuan Xu
Director/Board Member chez AKERO THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Yuan J.
Xu is an Independent Director at Fate Therapeutics, Xilio Therapeutics, and Akero Therapeutics.
Previously, Xu served as the Chief Executive Officer & Director at Legend Biotech Corp., General Manager & Vice President-Biologics at Gilead Sciences, Senior Vice President at Merck & Co., and Vice President at Novartis AG.
Xu holds a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
-.--% | 08/06/2020 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Yuan Xu
| Sociétés | Poste | Début |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 22/04/2021 |
| FATE THERAPEUTICS, INC. | Director/Board Member | 03/08/2021 |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 04/01/2022 |
Anciens postes connus de Yuan Xu
| Sociétés | Poste | Fin |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Chief Executive Officer | 01/08/2020 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/08/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/08/2015 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2014 |
Formation de Yuan Xu
| University of Maryland | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| AKERO THERAPEUTICS, INC. | Health Technology |
